Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 175 of 423 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/02
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 08/04/05
End: 03/07/07
Due: 03/07/08
Phase: N/A
Priority: Normal
Start: 01/28/03
End: 11/02/06
Due: 11/02/07
Phase: N/A
Priority: Normal
Start: 10/31/99
End: 12/31/05
Due: 12/31/06
Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
Phase: N/A
Priority: Normal
Start: 10/31/95
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/04/97
End: 11/05/12
Due: 11/05/13
Phase: N/A
Priority: Normal
Start: 08/31/99
End: 04/30/06
Due: 04/30/07
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 03/31/82
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 11/30/03
End: 07/31/05
Due: 07/31/06
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 02/17/09
End: 11/26/12
Due: 11/26/13
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 12/05/23
Due: 12/05/24
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 03/06/13
Due: 03/06/14
Phase: N/A
Priority: Normal
Start: 07/24/03
End: 02/06/07
Due: 02/06/08
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 01/18/22
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 08/31/02
Due: 08/31/03
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 03/31/01
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 08/05/03
End: 03/03/08
Due: 03/03/09
Phase: N/A
Priority: Normal
Start: 09/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/21/97
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/08/97
End: 09/15/14
Due: 09/15/15
Phase: N/A
Priority: Normal
Start: 05/31/94
End: 08/31/99
Due: 08/31/00